Pharmacokinetics and Safety of Ebastine in Patients with Impaired Hepatic Function Compared with Healthy Volunteers: A Phase I Open-Label Study

By Lasseter K.C.  

Clinical Pharmacokinetics, Vol. 43, Iss. 2, 2004-01 ,pp. : 121-129

Adis International

Access to resources Recommend Favorite

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

By Sekar V.  

Clinical Drug Investigation, Vol. 28, Iss. 8, 2008-01 ,pp. : 479-485

Adis International

Access to resources Recommend Favorite

Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open‐label, crossover phase 1 study

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 377-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open‐label, crossover phase 1 study

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 377-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK‐700) in Healthy Male Subjects: A Phase 1, Open‐Label, Single‐Dose Study

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 3, 2016-05 ,pp. : 180-187

John Wiley & Sons Inc

Access to resources Recommend Favorite